O Shaughnessy Asset Management LLC Takes Position in ICU Medical, Inc. (NASDAQ:ICUI)

O Shaughnessy Asset Management LLC bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 1,605 shares of the medical instruments supplier’s stock, valued at approximately $249,000.

Several other hedge funds and other institutional investors have also bought and sold shares of ICUI. Barclays PLC lifted its holdings in shares of ICU Medical by 15.6% in the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after acquiring an additional 8,010 shares during the last quarter. Principal Financial Group Inc. raised its position in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares during the period. Vanguard Group Inc. raised its position in ICU Medical by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock worth $416,176,000 after purchasing an additional 17,805 shares during the period. Jennison Associates LLC bought a new stake in ICU Medical in the fourth quarter worth $556,000. Finally, Geode Capital Management LLC boosted its position in ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after buying an additional 48,106 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on ICUI. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, April 4th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $168.67.

ICU Medical Stock Up 3.0 %

NASDAQ ICUI opened at $142.65 on Friday. The business’s 50-day moving average is $148.29 and its 200 day moving average is $160.95. The stock has a market capitalization of $3.50 billion, a PE ratio of -31.21 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.